Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis.

Literature DB >> 16251338

Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis.

Anthony W Solomon¹, Zeena Mohammed, Patrick A Massae, John F Shao, Allen Foster, David C W Mabey, Rosanna W Peeling.

Abstract

In a community of Tanzania where trachoma is endemic, we cultured conjunctival swabs from all residents who had active trachoma and were PCR positive for ocular Chlamydia trachomatis, both before (43 isolates) and 2 months after (9 isolates) mass antibiotic treatment. No clinically or programmatically significant increase in azithromycin or tetracycline resistance was observed.

Entities: Chemical Disease

Mesh：

Substances：
Azithromycin

Year: 2005 PMID： 16251338 PMCID： PMC1280160 DOI： 10.1128/AAC.49.11.4804-4806.2005

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

14 in total

Review 1. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.

Authors: Susan A Wang; John R Papp; Walter E Stamm; Rosanna W Peeling; David H Martin; King K Holmes
Journal: J Infect Dis Date: 2005-02-11 Impact factor: 5.226

2. Ocular levels of azithromycin.

Authors: K F Tabbara; S A al-Kharashi; S M al-Mansouri; O M al-Omar; H Cooper; A M el-Asrar; G Foulds
Journal: Arch Ophthalmol Date: 1998-12

3. A simple system for the assessment of trachoma and its complications.

Authors: B Thylefors; C R Dawson; B R Jones; S K West; H R Taylor
Journal: Bull World Health Organ Date: 1987 Impact factor: 9.408

4. Mass treatment with single-dose azithromycin for trachoma.

Authors: Anthony W Solomon; Martin J Holland; Neal D E Alexander; Patrick A Massae; Aura Aguirre; Angels Natividad-Sancho; Sandra Molina; Salesia Safari; John F Shao; Paul Courtright; Rosanna W Peeling; Sheila K West; Robin L Bailey; Allen Foster; David C W Mabey
Journal: N Engl J Med Date: 2004-11-04 Impact factor: 91.245

5. Global data on visual impairment in the year 2002.

Authors: Serge Resnikoff; Donatella Pascolini; Daniel Etya'ale; Ivo Kocur; Ramachandra Pararajasegaram; Gopal P Pokharel; Silvio P Mariotti
Journal: Bull World Health Organ Date: 2004-12-14 Impact factor: 9.408

6. Randomised controlled trial of single-dose azithromycin in treatment of trachoma.

Authors: R L Bailey; P Arullendran; H C Whittle; D C Mabey
Journal: Lancet Date: 1993-08-21 Impact factor: 79.321

Review 7. Trachoma.

Authors: David C W Mabey; Anthony W Solomon; Allen Foster
Journal: Lancet Date: 2003-07-19 Impact factor: 79.321

8. Strategies for control of trachoma: observational study with quantitative PCR.

Authors: Anthony W Solomon; Martin J Holland; Matthew J Burton; Sheila K West; Neal D E Alexander; Aura Aguirre; Patrick A Massae; Harran Mkocha; Beatriz Muñoz; Gordon J Johnson; Rosanna W Peeling; Robin L Bailey; Allen Foster; David C W Mabey
Journal: Lancet Date: 2003-07-19 Impact factor: 79.321

9. Sensitivity of immunofluorescence with monoclonal antibodies for detection of Chlamydia trachomatis inclusions in cell culture.

Authors: R S Stephens; C C Kuo; M R Tam
Journal: J Clin Microbiol Date: 1982-07 Impact factor: 5.948

10. Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp.

Authors: R J Suchland; W M Geisler; Walter E Stamm
Journal: Antimicrob Agents Chemother Date: 2003-02 Impact factor: 5.191

24 in total

1. Antibiotic resistance as collateral damage: the tragedy of the commons in a two-disease setting.

Authors: Daozhou Gao; Thomas M Lietman; Travis C Porco
Journal: Math Biosci Date: 2015-02-26 Impact factor: 2.144

Review 2. [Chlamydial diseases of the eye. A short overview].

Authors: W Behrens-Baumann
Journal: Ophthalmologe Date: 2007-01 Impact factor: 1.059

3. Trachoma: ancient scourge, disease elimination, and future research.

Authors: Charles Knirsch
Journal: Curr Infect Dis Rep Date: 2007-01 Impact factor: 3.725

4. Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control.

Authors: Jessica C Seidman; Christian L Coles; Ellen K Silbergeld; Joshua Levens; Harran Mkocha; Lashaunda B Johnson; Beatriz Muñoz; Sheila K West
Journal: Int J Epidemiol Date: 2014-03-21 Impact factor: 7.196

5. In vitro susceptibility of urogenital Chlamydia trachomatis strains in a country with high azithromycin consumption rate.

Authors: Suncanica Ljubin-Sternak; Tomislav Mestrovic; Tatjana Vilibic-Cavlek; Gordana Mlinaric-Galinovic; Mario Sviben; Alemka Markotic; Visnja Skerk
Journal: Folia Microbiol (Praha) Date: 2012-12-29 Impact factor: 2.099

6. Childhood Mortality After Mass Distribution of Azithromycin: A Secondary Analysis of the PRET Cluster-randomized Trial in Niger.

Authors: Kieran S O'Brien; Sun Y Cotter; Abdou Amza; Boubacar Kadri; Beido Nassirou; Nicole E Stoller; Zhaoxia Zhou; Sheila K West; Robin L Bailey; Jeremy D Keenan; Travis C Porco; Thomas M Lietman
Journal: Pediatr Infect Dis J Date: 2018-11 Impact factor: 2.129

Review 7. Trachoma.

Authors: Anthony W Solomon; Matthew J Burton; Emily W Gower; Emma M Harding-Esch; Catherine E Oldenburg; Hugh R Taylor; Lamine Traoré
Journal: Nat Rev Dis Primers Date: 2022-05-26 Impact factor: 52.329

Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis.

Review 1. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.

2. Ocular levels of azithromycin.

3. A simple system for the assessment of trachoma and its complications.

4. Mass treatment with single-dose azithromycin for trachoma.

5. Global data on visual impairment in the year 2002.

6. Randomised controlled trial of single-dose azithromycin in treatment of trachoma.

Review 7. Trachoma.

8. Strategies for control of trachoma: observational study with quantitative PCR.

9. Sensitivity of immunofluorescence with monoclonal antibodies for detection of Chlamydia trachomatis inclusions in cell culture.

10. Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp.

1. Antibiotic resistance as collateral damage: the tragedy of the commons in a two-disease setting.

Review 2. [Chlamydial diseases of the eye. A short overview].

3. Trachoma: ancient scourge, disease elimination, and future research.

4. Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control.

5. In vitro susceptibility of urogenital Chlamydia trachomatis strains in a country with high azithromycin consumption rate.

6. Childhood Mortality After Mass Distribution of Azithromycin: A Secondary Analysis of the PRET Cluster-randomized Trial in Niger.

Review 7. Trachoma.

8. Mass drug administration: the importance of synchrony.

9. Lack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachoma.

10. When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries.